Article
Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
23 Jan 2014
Abstract excerpt
The transplantation of mesenchymal stem cells (MSCs) for treating neurodegenerative disorders has received growing attention recently because these cells are readily available, easily expanded in culture, and when transplanted, survive for relatively long periods of time. Given that such transplants have been shown to be safe in a variety of applications, in addition to recent findings that MSCs have useful...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
